Clinical Trial Update: Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating burr hole therapy combined with erythropoietin for unstable Moyamoya disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Moyamoya Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Ischemic Attack, Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED